Boothbay Fund Management’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-42,263
Closed -$115K – 2214
2025
Q4
$115K Buy
42,263
+31,988
+311% +$105K ﹤0.01% 1730
2025
Q3
$43.5K Buy
+10,275
New +$45.2K ﹤0.01% 1796
2023
Q4
– Sell
-39,151
Closed -$220K – 1766
2023
Q3
$220K Buy
+39,151
New +$261K 0.01% 1396
2022
Q4
– Sell
-24,942
Closed -$116K – 2145
2022
Q3
$116K Buy
24,942
+14,935
+149% +$94.1K ﹤0.01% 2002
2022
Q2
$59K Buy
+10,007
New +$111K ﹤0.01% 2063

Other funds holding GDRX

Boothbay Fund Management's GDRX Position: Q1 2026 in Review

Boothbay Fund Management sold out of GoodRx Holdings (GDRX) in Q1 2026, closing a stake of 42,263 shares — an estimated $115K sold.

Boothbay Fund Management first reported a position in GDRX in Q2 2022 and held it in 5 quarters. The position peaked at $220K in Q3 2023. 177 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • Boothbay Fund Management reported no remaining GoodRx Holdings position as of Q1 2026 after selling out during the quarter.
  • Boothbay Fund Management sold 42,263 GoodRx Holdings shares in Q1 2026, an estimated $115K.
  • Boothbay Fund Management first reported a position in GoodRx Holdings in Q2 2022 and held it in 5 quarters.
  • Boothbay Fund Management's GoodRx Holdings position peaked at $220K in Q3 2023.
  • 177 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.